• OPEN AN ACCOUNT
Indian Indices
Nifty
26,068.15 -124.00
(-0.47%)
Sensex
84,900.71 -331.21
( -0.39%)
Bank Nifty
58,867.70 -480.00
( -0.81%)
Nifty IT
36,885.35 -157.95
( -0.43%)
Global Indices
Nasdaq
46,275.21 501.96
(1.10%)
Dow Jones
6,624.30 64.54
(0.98%)
Hang Seng
48,653.14 -1,170.80
(-2.35%)
Nikkei 225
9,535.95 8.30
(0.09%)
Forex
USD-INR
88.67 0.16
(0.19%)
EUR-INR
102.19 -0.14
(-0.14%)
GBP-INR
115.88 -0.12
(-0.10%)
JPY-INR
0.56 0.00
(-0.65%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
848.3143291
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
35.39
52070.28
EPS(TTM)
Face Value()
Div & Yield %
52.14
1
0.14
 

As on: Nov 24, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,841.05 -4.10 33439 35.39
Stock Price Details
Open Price() 1,845.20
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,860.60
Today's Low () 1,825.00
52-Week High () 2286.15
152-Week Low () 1274.7
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.14
Eps 52.14
Book Value 848.3143291
Market Cap (.Cr) 52,070.28
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Sep
ISIN No. INE935A01035


News
Cosmo and Glenmark receive EC marketing authorization for Winlevi®
Glenmark Pharma gets EC nod for acne drug Winlevi in 15 European countries
Glenmark Pharma gains after Q2 PAT climbs 72% YoY to Rs 610 cr
Nifty November futures trade at premium
Glenmark Pharmaceuticals consolidated net profit rises 72.31% in the September 2025 quarter
Glenmark Pharma Q2 PAT climbs 72% YoY to Rs 610 cr
Glenmark Pharmaceuticals Ltd spurts 2.55%, gains for third straight session
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark set to launch 8.4% Sodium Bicarbonate Injection USP, 50 mEq/50 mL (1 mEq/mL) Single-Dose Vial
Glenmark Pharma’s US subsidiary to launch 8.4% sodium bicarbonate injection in US market
More
Corporate Details
Incoporation Year   : 1977
Chairman : Glenn Saldanha
Bussiness Group : Indian Private
Registered Office
Glenmark Pharmaceuticals Ltd
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40189999
Fax:91-22-40189986
Fax:91-22-66317458
E-Mail : complianceofficer@glenmarkpharma.com
URL : http://www.glenmarkpharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE Midcap
  • BSE Shariah 50
  • MIDCAP 200
  • CNX 500
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi